Lobbying

Mariposa Health's latest lobbying report covers Q1 2023, at $60K. Its first report covers Q4 2022; the issues it reports most are Civil Rights/Civil Liberties and Health Issues.

Mariposa Health

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Mariposa Health lobbying by quarter
Mariposa Health lobbying by quarter
QuarterAmountReports
Q4 2022$60K1
Q1 2023$60K1
Q2 2023$00
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Civil rights and liberties$40K · 2 reports
  • Health issues$40K · 2 reports
  • Pharmacy$40K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health & Human Services, Dept of (HHS)2 reports
  • HOUSE OF REPRESENTATIVES2 reports
  • SENATE2 reports
  • White House Office2 reports
  • Executive Office of the President (EOP)1 reports

Firms it paid

Firm
Mehlman Consulting$120K2 quarters

Former officials lobbying for it

Former position
CAITLIN VAN SANTSr Pol Adv, Leg Dir, Interim COS (Rep. Butterfield)Q4 2022
LISA GOLDMANSr Counsel, House Comm on Energy & Commerce; Chief Counsel, Sr Counsel (E&C Subcommittee on Consumer Protection & Commerce); Counsel House Comm on E&CQ4 2022

Lobbying reports

Filed by
23/04/20for Q1 2023Mehlman Consulting$60K
23/01/20for Q4 2022Mehlman Consulting$60K